Monday, March 30, 2009

Obesity Drug Development Is Tough — Just Ask Arena

The company said its obesity drug hit key targets, but the market was underwhelmed and the stock fell sharply.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)